Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.verified

1349.HK

Price:

$2.6

Market Cap:

$800.65M

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, manufactures, and sells bio-pharmaceutical products. It offers genetic engineering platform drugs, including CD30-DM1 antibody-drug conjugate (ADC), which is in Phase I clinical trials for tumors; Trop2-SN38 ADC that is in Phase I clinical trials for triple negative, breast, bladder, gastric, and other tumors; Trop2-BB05 ADC that is in pre-clinical studies for lung cancer and triple negative breast cancer; and HER2 ADC that has completed pre-clinical research for metastatic breast and gastric cancers. The company also provides photodynamic technical platform drugs, such as hemoporfin...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2002-08-13

Stock Exchange

HKSE

Ticker

1349.HK

The PE Ratio as of May 2025 (TTM) for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (1349.HK) is 65.00

According to Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 65.00. This represents a change of -70.94% compared to the average of 223.68 of the last 4 quarters.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (1349.HK) Historical PE Ratio (quarterly & annually)

How has 1349.HK PE Ratio performed in the past?

The mean historical PE Ratio of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. over the last ten years is 186.59. The current 65.00 PE Ratio has changed 3.38% with respect to the historical average. Over the past ten years (40 quarters), 1349.HK's PE Ratio was at its highest in in the March 2019 quarter at 1.74K. The PE Ratio was at its lowest in in the March 2020 quarter at -460.07.

Quarterly (TTM)
Annual

Average

186.59

Median

175.15

Minimum

62.34

Maximum

453.61

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (1349.HK) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 129.48%

Maximum Annual PE Ratio = 453.61

Minimum Annual Increase = -50.14%

Minimum Annual PE Ratio = 62.34

Quarterly (TTM)
Annual
YearPE RatioChange
2024200.09129.48%
202387.2039.88%
202262.34-9.39%
202168.80-33.78%
2020103.89-30.84%
2019150.21-33.59%
2018226.19-50.14%
2017453.6184.24%
2016246.21-7.92%
2015267.38-7.41%

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (1349.HK) Average PE Ratio

How has 1349.HK PE Ratio performed in the past?

The current PE Ratio of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (1349.HK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

116.54

5-year avg

104.46

10-year avg

186.59

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (1349.HK) PE Ratio vs. Peers

How is 1349.HK’s PE Ratio compared to its peers?

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.’s PE Ratio is greater than Dynagreen Environmental Protection Group Co., Ltd. (15.74), less than Shanghai Fudan Microelectronics Group Company Limited (67.17), greater than China Pioneer Pharma Holdings Limited (15.78), greater than LifeTech Scientific Corporation (27.91), greater than PW Medtech Group Limited (9.88),

Build a custom stock screener for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (1349.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (1349.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.'s PE Ratio?

How is the PE Ratio calculated for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (1349.HK)?

What is the highest PE Ratio for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (1349.HK)?

What is the 3-year average PE Ratio for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (1349.HK)?

What is the 5-year average PE Ratio for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (1349.HK)?

How does the current PE Ratio for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (1349.HK) compare to its historical average?